Correlation Between Bellevue Life and BaringtonHilco Acquisition

Can any of the company-specific risk be diversified away by investing in both Bellevue Life and BaringtonHilco Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bellevue Life and BaringtonHilco Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bellevue Life Sciences and BaringtonHilco Acquisition, you can compare the effects of market volatilities on Bellevue Life and BaringtonHilco Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bellevue Life with a short position of BaringtonHilco Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bellevue Life and BaringtonHilco Acquisition.

Diversification Opportunities for Bellevue Life and BaringtonHilco Acquisition

0.0

Correlation Coefficient

Bellevue Life  BaringtonHilco Acquisition

Pay attention - limited upside

The 3 months correlation between Bellevue and BaringtonHilco is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bellevue Life Sciences and BaringtonHilco Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BaringtonHilco Acquisition and Bellevue Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bellevue Life Sciences are associated (or correlated) with BaringtonHilco Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BaringtonHilco Acquisition has no effect on the direction of Bellevue Life i.e., Bellevue Life and BaringtonHilco Acquisition go up and down completely randomly.

Pair Corralation between Bellevue Life and BaringtonHilco Acquisition

If you would invest (100.00) in BaringtonHilco Acquisition on December 5, 2024 and sell it today you would earn a total of  100.00  from holding BaringtonHilco Acquisition or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Bellevue Life Sciences  vs.  BaringtonHilco Acquisition

Bellevue Life Sciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bellevue Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

BaringtonHilco Acquisition

Risk-Adjusted Performance

Very Weak

Over the last 90 days BaringtonHilco Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BaringtonHilco Acquisition is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Bellevue Life and BaringtonHilco Acquisition

The main advantage of trading using opposite Bellevue Life and BaringtonHilco Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bellevue Life position performs unexpectedly, BaringtonHilco Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BaringtonHilco Acquisition will offset losses from the drop in BaringtonHilco Acquisition's long position.

The idea behind Bellevue Life Sciences and BaringtonHilco Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.